Print this page

Targeted Cancer Therapy

Nordic Nanovector AS is a privately held company based in Oslo, Norway. The company was established in 2009. Our mission is to develop innovative radioimmunotherapeutics that target difficult to treat cancers using the company’s proprietary nanovector targeting technology.

Nordic Nanovector intends to commercialise its product candidates through strategic alliances and partnerships with experienced oncology businesses and by establishing its own sales and marketing capabilities in selected markets.




September 16, 2014
Nordic Nanovector: – Final result of the subsequent offering
Press Relase 26/2014. See link for details.

September 15, 2014
Nordic Nanovector: – Preliminary result of the subsequent offering
Press Relase 25/2014. See link for details.

September 1, 2014
Nordic Nanovector: – Subsequent Offering
Press Relase 24/2014. See link for details.











Next page: About us